Company intelligence / Profile preview

ZBeats

Stony Brook, New York, United Stateszbeats.co ↗

Ownership: Private
Development stage: Commercial

Overview

ZBeats offers an FDA-compliant medical-grade solution for ambulatory cardiac monitoring. Its proprietary AI-driven platform detects common and advanced arrhythmias from wearable ECG data. The company has received SBIR/STTR grants to develop next-generation systems leveraging digital twins. Clinical results focus on improved diagnostic accuracy and operational productivity in real-world settings. No published pivotal trial data found; product appears commercially available with ongoing R&D collaborations.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware as a Medical Device (SaMD)Artificial intelligence-based diagnosticsWearable device
Industry: Physiological Monitoring

Partnerships

Stony Brook University CEWIT/MTRC partnership for research/manufacturing support

Beyond the preview

Go deeper on ZBeats.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZBeats.

Explore the full profile